Viyash Scientific Limited (BOM:512529)
India · Delayed Price · Currency is INR 226.05
+0.25 (0.11%)
At close: Oct 16, 2026
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 98.66 billion as of October 16, 2026. It is the 9,913th most valuable company in the world and the 595th biggest in India. Its market cap has increased by 84.11% in one year.
Market Cap
98.66B
Enterprise Value
103.00B
Revenue
35.75B
Global Rank
Country Rank
#595 India
PE Ratio
47.61
ChartMarket Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 98.66B, an increase of 28,271.67%. That is a compound annual growth rate of 29.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 98.66B | 8.78% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Granules India | 204.61B |
| Caplin Point Laboratories | 174.84B |
| Jubilant Pharmova | 149.58B |
| AstraZeneca Pharma India | 149.15B |
| Procter & Gamble Health | 86.41B |
| Bliss GVS Pharma | 70.05B |
| Sanofi India | 67.75B |
| Morepen Laboratories | 67.73B |